


Qulipta—Preventive power that has your
migraine patients covered
- The recommended dose is 10 mg, 30 mg, or 60 mg orally once daily.
- Concomitant Strong and Moderate CYP3A4 Inducers: Recommended dose is 30 mg or 60 mg once daily
- Concomitant OATP Inhibitors: Recommended dose is 10 mg or 30 mg once daily
- Severe Renal Impairment: Recommended dose is 10 mg once daily
- Concomitant Strong CYP3A4 Inhibitors: Recommended dose is 10 mg once daily
- End-Stage Renal Disease: Recommended dose is 10 mg once daily
Avoid use in patients with severe hepatic impairment.
see efficacy Results